AIMS/HYPOTHESIS: HNF1A-MODY is a monogenic form of diabetes caused by mutations in the HNF1A gene. Here we identify, for the first time, HNF1A-MODY-associated microRNAs (miRNAs) that can be detected in the serum of HNF1A-MODY carriers. METHODS: An miRNA array was carried out in rat INS-1 insulinoma cells inducibly expressing the common human Pro291fsinsC-HNF1A frame shift mutation. Differentially expressed miRNAs were validated by quantitative real-time PCR. Expression of miRNAs in the serum of HNF1A-MODY carriers (n = 31), MODY-negative family members (n = 10) and individuals with type 2 diabetes mellitus (n = 17) was quantified by absolute real-time PCR analysis. RESULTS: Inducible expression of Pro291fsinsC-HNF1A in INS-1 cells caused a significant upregulation of three miRNAs (miR-103, miR-224, miR-292-3p). The differential expression of two miRNAs (miR-103 and miR-224) was validated in vitro. Strongly elevated levels of miR-103 and miR-224 could be detected in the serum of HNF1A-MODY carriers compared with MODY-negative family controls. Serum levels of miR-103 distinguished HNF1A-MODY carriers from HbA1c-matched individuals with type 2 diabetes mellitus. CONCLUSIONS/ INTERPRETATION: Our study demonstrates that the pathophysiology of HNF1A-MODY is associated with the overexpression of miR-103 and miR-224. Furthermore, our study demonstrates that these miRNAs can be readily detected in the serum of HNF1A-MODY carriers.
AIMS/HYPOTHESIS: HNF1A-MODY is a monogenic form of diabetes caused by mutations in the HNF1A gene. Here we identify, for the first time, HNF1A-MODY-associated microRNAs (miRNAs) that can be detected in the serum of HNF1A-MODY carriers. METHODS: An miRNA array was carried out in ratINS-1 insulinoma cells inducibly expressing the common human Pro291fsinsC-HNF1A frame shift mutation. Differentially expressed miRNAs were validated by quantitative real-time PCR. Expression of miRNAs in the serum of HNF1A-MODY carriers (n = 31), MODY-negative family members (n = 10) and individuals with type 2 diabetes mellitus (n = 17) was quantified by absolute real-time PCR analysis. RESULTS: Inducible expression of Pro291fsinsC-HNF1A in INS-1 cells caused a significant upregulation of three miRNAs (miR-103, miR-224, miR-292-3p). The differential expression of two miRNAs (miR-103 and miR-224) was validated in vitro. Strongly elevated levels of miR-103 and miR-224 could be detected in the serum of HNF1A-MODY carriers compared with MODY-negative family controls. Serum levels of miR-103 distinguished HNF1A-MODY carriers from HbA1c-matched individuals with type 2 diabetes mellitus. CONCLUSIONS/ INTERPRETATION: Our study demonstrates that the pathophysiology of HNF1A-MODY is associated with the overexpression of miR-103 and miR-224. Furthermore, our study demonstrates that these miRNAs can be readily detected in the serum of HNF1A-MODY carriers.
Authors: P J Kaisaki; S Menzel; T Lindner; N Oda; I Rjasanowski; J Sahm; G Meincke; J Schulze; H Schmechel; C Petzold; H M Ledermann; G Sachse; V V Boriraj; R Menzel; W Kerner; R C Turner; K Yamagata; G I Bell Journal: Diabetes Date: 1997-03 Impact factor: 9.461
Authors: Anna Zampetaki; Stefan Kiechl; Ignat Drozdov; Peter Willeit; Ursula Mayr; Marianna Prokopi; Agnes Mayr; Siegfried Weger; Friedrich Oberhollenzer; Enzo Bonora; Ajay Shah; Johann Willeit; Manuel Mayr Journal: Circ Res Date: 2010-07-22 Impact factor: 17.367
Authors: Matthew N Poy; Lena Eliasson; Jan Krutzfeldt; Satoru Kuwajima; Xiaosong Ma; Patrick E Macdonald; Sébastien Pfeffer; Thomas Tuschl; Nikolaus Rajewsky; Patrik Rorsman; Markus Stoffel Journal: Nature Date: 2004-11-11 Impact factor: 49.962
Authors: Zsuzsanna Lichner; Salvador Mejia-Guerrero; Monika Ignacak; Adriana Krizova; Tian Tian Bao; Andrew H F Girgis; Yousef M Youssef; George M Yousef Journal: Am J Pathol Date: 2012-02-09 Impact factor: 4.307
Authors: Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall Journal: Nat Cell Biol Date: 2007-05-07 Impact factor: 28.824
Authors: B M Herrera; H E Lockstone; J M Taylor; M Ria; A Barrett; S Collins; P Kaisaki; K Argoud; C Fernandez; M E Travers; J P Grew; J C Randall; A L Gloyn; D Gauguier; M I McCarthy; C M Lindgren Journal: Diabetologia Date: 2010-03-03 Impact factor: 10.122
Authors: Wigard P Kloosterman; Anne K Lagendijk; René F Ketting; Jon D Moulton; Ronald H A Plasterk Journal: PLoS Biol Date: 2007-08 Impact factor: 8.029
Authors: Wojciech Fendler; Joanna Madzio; Kamil Kozinski; Kashyap Patel; Justyna Janikiewicz; Magdalena Szopa; Adam Tracz; Maciej Borowiec; Przemyslawa Jarosz-Chobot; Malgorzata Mysliwiec; Agnieszka Szadkowska; Andrew T Hattersley; Sian Ellard; Maciej T Malecki; Agnieszka Dobrzyn; Wojciech Mlynarski Journal: Diabetologia Date: 2016-04-08 Impact factor: 10.122
Authors: Anja Elaine Sørensen; Mireille N M van Poppel; Gernot Desoye; David Simmons; Peter Damm; Dorte Møller Jensen; Louise Torp Dalgaard Journal: Biomedicines Date: 2022-02-18
Authors: E B Amankwatia; P Chakravarty; F A Carey; S Weidlich; R J C Steele; A J Munro; C R Wolf; G Smith Journal: Br J Cancer Date: 2015-04-28 Impact factor: 7.640
Authors: Shona Pfeiffer; Begoña Sánchez-Lechuga; Paul Donovan; Luise Halang; Jochen H M Prehn; Antonio Campos-Caro; Maria M Byrne; Cristina López-Tinoco Journal: Sci Rep Date: 2020-01-22 Impact factor: 4.379